Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2022

May 19, 2022

33018_dirs_2022-05-19_c3ab4ff9-ec98-418c-969d-d4b24926bd54.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2022-05-17

Reporting Person: Ashe Gena L (Chief Legal Officer & Corp Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-05-17 Common Stock A 9112 $0.00 Acquired 42811 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-17 Stock Option (Right to Buy) $49.39 A 18368 Acquired 2032-05-17 Common Stock (18368) Direct

Footnotes

F1: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter.

F2: 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.